The Ceftazidime for Injection, cataloged under National Stock Number 6505-01-300-2115, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Abbott Laboratories Inc. Div Hospital Products Division. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-300-2115 |
| Primary Part Number | K5086-11 |
| Item Name | Ceftazidime for Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Abbott Laboratories Inc. Div Hospital Products Division |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR OR INTRAVENOUS |
| Primary Container Content Quantity | 6.000 GRAMS OF ACTIVE INGREDIENT G |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL, MULTIPLE DOSE |
| Physical Form | POWDER |
| Active Medicament Medicinal Strength | 6.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT G |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| K5086-11 PRIMARY | Abbott Laboratories Inc. Div Hospital Products Division (USA) |
| Reference | Meaning |
|---|---|
| MA 89-288 | 3/2 Design control — primary reference U.S. Government activity |
NSN 6505-01-300-2115 is a Ceftazidime for Injection, manufactured by Abbott Laboratories Inc. Div Hospital Products Division, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-300-2115 has 1 manufacturer part number on file: K5086-11 (Abbott Laboratories Inc. Div Hospital Products Division).
Key specifications for K5086-11: Administration: INTRAMUSCULAR OR INTRAVENOUS; Primary Container Content Quantity: 6.000 GRAMS OF ACTIVE INGREDIENT G; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL, MULTIPLE DOSE. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.